NCT07094646Completed
Full Assessment of Clinical Transfusion Support
An Assessment of Hematologic Diseases Among Blood Transfusion Recipients and Donated Units at a Pediatric Regional Referral Hospital in Uganda
Source: ClinicalTrials.gov · Last updated 30 Jul 2025
Brief summary (registry, in English)
This study looks at why some children develop very severe anemia that leads to a blood transfusion. It also checks for diseases in the blood they receive. Researchers are using small samples of dried blood (called dried blood spots) from both the children and the donated blood to find out what might be causing the anemia.
- Status (registry)
- Completed
- Study type
- Observational
- Enrollment
- 250 (actual)
- First submitted
- 23 Jul 2025
- Start date
- 21 Sept 2023
- Primary completion date
- 19 Mar 2024
- Lead sponsor
- Children's Hospital Medical Center, Cincinnati
- Diseases
- Sickle cell disease
- NCT number
- NCT07094646
What you commit to
- Study type: Observational
- Participants enrolled: 250
- From 21 Sept 2023 to the primary completion date, 19 Mar 2024
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- If receiving a blood transfusion, refusal or inability to sign an informed consent.
Who the study is looking for
- Children receiving a blood transfusion in Eastern Uganda at Jinja Regional Referral Hospital.
Sex: All · Accepts healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Jinja Regional Referral Hospital (JRRH) Coordinator of this site? Confirm its status | Jinja | Uganda | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.